Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Neutral
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Website
Compumedics LimitedTelephone
61.3.8420.7300
Address
30-40 Flockhart Street Abbotsford, Victoria (VIC) 3067
Description
Compumedics Ltd. engages in the research, development, manufacture, and distribution of medical equipment and associated technologies. It offers innovative computer-based diagnostic technologies in the areas of sleep, neurology, and cardiology. The firm operates through the following geographical segments: Americas, Australia and Asia Pacific, and Europe and the Middle East. The Americas segment includes the United States, Canada, and Latin America. The Australia and Asia Pacific segment refers to all countries in the Asia Pacific region with major countries for the territory including Japan and China. The Europe and the Middle East segment focuses on all countries in the European region and all Middle Eastern countries. The company was founded by David Burton in 1987 and is headquartered in Abbotsford, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.16 - 0.44
Trade Value (12mth)
AU$3,182.00
1 week
-4.92%
1 month
-4.92%
YTD
3.57%
1 year
52.63%
All time high
0.96
EPS 3 yr Growth
-133.90%
EBITDA Margin
1.50%
Operating Cashflow
$2m
Free Cash Flow Return
10.30%
ROIC
-1.70%
Interest Coverage
1.00
Quick Ratio
0.60
Shares on Issue (Fully Dilluted)
177m
HALO Sector
Healthcare
Next Company Report Date
01-Sep-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
01 November 24 |
Results of Meeting
×
Results of Meeting |
01 November 24 |
Results of Meeting
×
Results of Meeting |
31 October 24 |
Chair's Address to Shareholders
×
Chair's Address to Shareholders |
17 October 24 |
Business Update
×
Business Update |
01 October 24 |
Governance Statement
×
Governance Statement |
01 October 24 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
30 September 24 |
Full Year Statutory Accounts
×
Full Year Statutory Accounts |
30 September 24 |
Appendix 4G
×
Appendix 4G |
06 September 24 |
FY2024 full year update
×
FY2024 full year update |
30 August 24 |
Preliminary Final Report
×
Preliminary Final Report |
06 August 24 |
Europe Trading Update
×
Europe Trading Update |
16 July 24 |
Business Update FY24
×
Business Update FY24 |
12 July 24 |
Application for quotation of securities - CMP
×
Application for quotation of securities - CMP |
12 July 24 |
Placement
×
Placement |
04 July 24 |
Placement
×
Placement |
04 July 24 |
Proposed issue of securities - CMP
×
Proposed issue of securities - CMP |
04 July 24 |
Update - Proposed issue of securities - CMP
×
Update - Proposed issue of securities - CMP |
04 July 24 |
Proposed issue of securities - CMP
×
Proposed issue of securities - CMP |
02 July 24 |
Trading Halt
×
Trading Halt |
17 June 24 |
USA Somfit HST Key Appointment
×
USA Somfit HST Key Appointment |
06 June 24 |
Corporate Presentation June 2024
×
Corporate Presentation June 2024 |
23 May 24 |
FY24 Business Update
×
FY24 Business Update |
29 February 24 |
Half Yearly Report and Accounts
×
Half Yearly Report and Accounts |
29 February 24 |
Compumedics Leaps back to profits and growth
×
Compumedics Leaps back to profits and growth |
11 January 24 |
Business Update December 31
×
Business Update December 31 |
12 December 23 |
$9.3m MEG sales to China
×
$9.3m MEG sales to China |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.